Lawrence Klein was appointed as the CEO of Oruka Therapeutics, Inc. on August 12, 2025.
3 reports, 2 independent
Updated 00:00
No new developments lately
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lawrence Klein was appointed as the CEO of Oruka Therapeutics, Inc. on August 12, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.CEO Lawrence Klein sold Oruka Therapeutics stock, disclosing the insider sale to the SEC.1 source
- Oruka Therapeutics promoted Laura Sandler on July 2, 2025.Sub-event
Lawrence Klein takes the helm as CEO of Oruka Therapeutics.1 source
Keep exploring
The entities involved
-
Lawrence Klein
chess player
Nothing else this week.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- GlobeNewswireOruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update First patients dosed in the EVERLAST-A Phase 2a trial of ORKA-001, with data expected in 2H 2026 ORKA-00